PRF Technologies Ltd.
$2.64
▼
-0.47%
2026-04-21 08:56:01
www.painreform.com
NCM: PRFX
Explore PRF Technologies Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.31 M
Current Price
$2.64
52W High / Low
$17.95 / $1.8
Stock P/E
—
Book Value
$10.29
Dividend Yield
—
ROCE
-53.59%
ROE
-90.37%
Face Value
—
EPS
$-7.47
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6
Beta
0.71
Debt / Equity
0.23
Current Ratio
1.78
Quick Ratio
1.78
Forward P/E
-0.22
Price / Sales
131.65
Enterprise Value
$-1.14 M
EV / EBITDA
0.26
EV / Revenue
-66.79
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Phibro Animal Health Corporation | $56.51 | 24.91 | $2.29 B | 0.85% | 10.35% | 31.8% | $60.08 / $16.16 | $8.2 |
| 2. | Amphastar Pharmaceuticals, Inc. | $22.92 | 10.43 | $1.02 B | — | 9.54% | 12.9% | $31.26 / $17.03 | $17.28 |
| 3. | Evolus, Inc. | $5.08 | — | $330.5 M | — | -24.97% | 587.36% | $12.28 / $3.86 | $-0.35 |
| 4. | Kiniksa Pharmaceuticals International, plc | $42.46 | 55.07 | $3.25 B | — | 12.37% | 11.73% | $50.03 / $19.62 | $7.44 |
| 5. | Alpha Teknova, Inc. | $2.91 | — | $157.01 M | — | -17.67% | -22.83% | $7.48 / $1.91 | $1.28 |
| 6. | Aquestive Therapeutics, Inc. | $4.24 | — | $527.23 M | — | -62.98% | 178.61% | $7.55 / $2.12 | $-0.28 |
| 7. | Anika Therapeutics, Inc. | $15.82 | — | $213.74 M | — | -6.56% | -6.71% | $16.02 / $7.87 | $10.33 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.02 M | 0 M | 0 M | 0 M |
| Operating Profit | -5.12 M | -14.67 M | -9.58 M | -8.87 M |
| Net Profit | -5.02 M | -14.59 M | -9.34 M | -8.79 M |
| EPS in Rs | -5.95 | -17.27 | -11.06 | -10.41 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 12 M | 4.53 M | 9.93 M | 12.33 M |
| Total Liabilities | 2.71 M | 2.7 M | 2.69 M | 1.31 M |
| Equity | 8.54 M | 1.82 M | 7.24 M | 11.02 M |
| Current Assets | 4.35 M | 4.43 M | 9.8 M | 12.28 M |
| Current Liabilities | 2.44 M | 2.44 M | 2.41 M | 1.06 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.96 M | -12.62 M | -6.68 M | -6.46 M |
| Investing CF | -0.98 M | -0.01 M | 5.99 M | -6.01 M |
| Financing CF | 3.82 M | 8.86 M | 4.62 M | 0 M |
| Free CF | -3.96 M | -12.63 M | -6.69 M | -6.46 M |
| Capex | -0 M | -0.01 M | -0.01 M | -0.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -56.12% | -6.28% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-06 | 1:0.2 |
| 2024-09-09 | 1:0.166667 |
| 2023-07-03 | 1:0.1 |